Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/
View Top Employees from AgenusWebsite | https://agenusbio.com/ |
Ticker | AGEN |
Revenue | $309.9 million |
Funding | $462.1 million |
Employees | 358 (358 on RocketReach) |
Founded | 1994 |
Address | 3 Forbes Road, Lexington, Massachusetts 02421, US |
Phone | (781) 674-4400 |
Fax | (781) 674-4200 |
Technologies |
JavaScript,
HTML,
PHP
+88 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Immuno-oncology, Healthcare, Cancer Vaccines, Checkpoint Inhibitors and Modulators |
Keywords | Cancer Treatment, Infectious Disease Treatments, Cancer Research |
Competitors | Celldex Therapeutics, Dendreon, MacroGenics, Inc., Sorrento Therapeutics, Inc., Virótica Digital |
SIC | SIC Code 283 Companies, SIC Code 873 Companies, SIC Code 28 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 3332 Companies, NAICS Code 333 Companies, NAICS Code 33 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Agenus employee's phone or email?
The Agenus annual revenue was $309.9 million in 2024.
Robin Taylor is the Chief Commercial Officer of Agenus.
358 people are employed at Agenus.
Agenus is based in Lexington, Massachusetts.
The NAICS codes for Agenus are [3332, 333, 33, 32, 325].
The SIC codes for Agenus are [283, 873, 28, 87].